Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Objective.: Biomarkers of progression of interstitial lung disease (ILD) are needed to allow early therapeutic intervention in patients with scleroderma-associated disease (SSc-ILD). Methods.: A panel of 8 serum cytokines [interleukin 6 (IL-6), IL-8, IL-10, CCL2, CXCL10, vascular endothelial growth factor, fibroblast growth factor 2, and CX3CL1] was assessed by Luminex bead technology in exploratory cohorts of 74 patients with SSc and 58 patients with idiopathic pulmonary fibrosis (IPF). Mortality and significant lung function decline [forced vital capacity (FVC) ≥ 10%; DLCO ≥ 15%] from date of serum collection were evaluated by proportional hazards analysis. Based on these findings, the prognostic value of serum IL-6, evaluated by ELISA, was assessed in a larger test cohort of 212 patients with SSc-ILD. Results.: In the exploratory cohort, only serum IL-6 was an independent predictor of DLCO decline in both IPF and SSc-ILD. The IL-6 threshold level most predictive of DLCO decline within a year was 7.67 pg/ml. In the larger test cohort, serum IL-6 > 7.67 pg/ml was predictive of decline in FVC (HR 2.58 ± 0.98, p = 0.01) and in DLCO (HR 3.2 ± 1.7, p = 0.02) within the first year, and predictive of death within the first 30 months (HR 2.69 ± 0.96, p = 0.005). When stratified according to severity (FVC < 70%), serum IL-6 > 7.67 pg/ml was predictive of functional decline or death within the first year in patients with milder disease (OR 3.1, 95% CI 1.4–7.2, p = 0.007), but not in those with severe ILD. Conclusion.: In SSc-ILD, serum IL-6 levels appear to be predictive of early disease progression in patients with mild ILD, and could be used to target treatment in this group, if confirmed by prospective studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
Masi, A. T., & Subcommittee For Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230510 · Cited by 4,898
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Changes in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System
Goh, N. S. L., Desai, S. R., Veeraraghavan, S., Hansell, D. M., Copley, S. J., Maher, T. M., Corte, T. J., Sander, C. R., Ratoff, J., Devaraj, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-877oc · Cited by 1,230
Self-citationFERRI, C., VALENTINI, G., COZZI, F., SEBASTIANI, M., MICHELASSI, C., LA MONTAGNA, G., BULLO, A., CAZZATO, M., TIRRI, E., STORINO, F., et al. (2002) · Medicine · doi:10.1097/00005792-200203000-00004 · Cited by 764
Wells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2111053 · Cited by 686
Self-citationLineage commitment in the immune system: the T helper lymphocyte grows up
Glimcher, L. H., & Murphy, K. M. (2000) · Genes & Development · doi:10.1101/gad.14.14.1693 · Cited by 623
Severe restrictive lung disease in systemic sclerosis
Steen, V. D., Conte, C., Owens, G. R., & Medsger, T. A. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370903 · Cited by 526
Desai, S. R., Veeraraghavan, S., Hansell, D. M., Nikolakopolou, A., Goh, N. S. L., Nicholson, A. G., Colby, T. V., Denton, C. P., Black, C. M., du Bois, R. M., et al. (2004) · Radiology · doi:10.1148/radiol.2322031223 · Cited by 394
Self-citationDuncan, M. R., & Berman, B. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12483971 · Cited by 323
Sato, S., Hasegawa, M., & Takehara, K. (2001) · Journal of Dermatological Science · doi:10.1016/s0923-1811(01)00128-1 · Cited by 297
TAKAHASHI, H., FUJISHIMA, T., KOBA, H., MURAKAMI, S., KUROKAWA, K., SHIBUYA, Y., SHIRATORI, M., KUROKI, Y., & ABE, S. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9910080 · Cited by 291
Wells, A. U., Cullinan, P., Hansell, D. M., Rubens, M. B., Black, C. M., Newman-Taylor, A. J., & Du Bois, R. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.6.8004317 · Cited by 265
Self-citationSCALA, E., PALLOTTA, S., FREZZOLINI, A., ABENI, D., BARBIERI, C., SAMPOGNA, F., DE PITÀ, O., PUDDU, P., PAGANELLI, R., & RUSSO, G. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02642.x · Cited by 231
Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.
Wells, A. U., Rubens, M. B., du Bois, R. M., & Hansell, D. M. (1993) · American Journal of Roentgenology · doi:10.2214/ajr.161.6.8249719 · Cited by 212
Self-citationSerum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary Fibrosis
Kinder, B. W., Brown, K. K., McCormack, F. X., Ix, J. H., Kervitsky, A., Schwarz, M. I., & King, T. E. (2009) · Chest · doi:10.1378/chest.08-2209 · Cited by 209
Bosello, S., De Santis, M., Lama, G., Spanò, C., Angelucci, C., Tolusso, B., Sica, G., & Ferraccioli, G. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2965 · Cited by 199
Bryan, C., Knight, C., Black, C. M., & Silman, A. J. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199912)42:12<2660::aid-anr23>3.0.co;2-n · Cited by 190
Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis
Collard, H. R., Calfee, C. S., Wolters, P. J., Song, J. W., Hong, S.-B., Brady, S., Ishizaka, A., Jones, K. D., King, T. E., Matthay, M. A., et al. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90637.2008 · Cited by 186
de Lauretis, A., Veeraraghavan, S., & Renzoni, E. (2011) · Chronic Respiratory Disease · doi:10.1177/1479972310393758 · Cited by 182
Self-citationHANT, F. N., LUDWICKA-BRADLEY, A., WANG, H.-J., LI, N., ELASHOFF, R., TASHKIN, D. P., & SILVER, R. M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080633 · Cited by 177
Goh, N. S. L., Veeraraghavan, S., Desai, S. R., Cramer, D., Hansell, D. M., Denton, C. P., Black, C. M., du Bois, R. M., & Wells, A. U. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22696 · Cited by 177
Self-citationTH-17 differentiation: of mice and men
Laurence, A., & O'Shea, J. J. (2007) · Nature Immunology · doi:10.1038/ni0907-903 · Cited by 167
Koch, A. E., Kronfeld-Harrington, L. B., Szekanecz, Z., Cho, M. M., Haines, K., Harlow, L. A., Strieter, R. M., Kunkel, S. L., Massa, M. C., Barr, W. G., et al. (1993) · Pathobiology · doi:10.1159/000163802 · Cited by 158
Gene expression profiling reveals novel TGFβ targets in adult lung fibroblasts
Renzoni, E. A., Abraham, D., Howat, S., Shiwen, X., Sestini, P., Bou–Gharios, G., Wells, A. U., Veeraraghavan, S., Nicholson, A. G., Denton, C. P., et al. (2004) · Respiratory Research · doi:10.1186/1465-9921-5-24 · Cited by 144
Self-citationMuangchan, C., Harding, S. E., Khimdas, S., Bonner, A., Baron, M. G., & Pope, J. E. (2012) · Arthritis Care & Research · doi:10.1002/acr.21716 · Cited by 140
Hasegawa, M., Sato, S., Fujimoto, M., Ihn, H., Kikuchi, K., & Takehara, K. (1998) · PubMed · Cited by 138
Yanaba, K., Hasegawa, M., Takehara, K., & Sato, S. (2004) · PubMed · Cited by 136
IL-6 induces hepatic inflammation and collagen synthesisin vivo
CHOI, I., KANG, H.-S., Yang, Y. M., & Pyun, K. H. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb07031.x · Cited by 127
Corte, T. J., Wort, S. J., Gatzoulis, M. A., Macdonald, P., Hansell, D. M., & Wells, A. U. (2009) · Thorax · doi:10.1136/thx.2008.112847 · Cited by 117
Self-citationSerum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis
TIEV, K. P., Hua-Huy, T., Kettaneh, A., Gain, M., Duong‐Quy, S., Tolédano, C., Cabané, J., & Dinh‐Xuan, A. T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00004711 · Cited by 110
Different Angiogenic Activity in Pulmonary Sarcoidosis and Idiopathic Pulmonary Fibrosis
Antoniou, K. M., Τzouvelekis, Α., Alexandrakis, M. G., Sfiridaki, K., Tsiligianni, I., Rachiotis, G., Tzanakis, Ν., Bouros, D. E., Milic‐Emili, J., & Siafakas, N. M. (2006) · CHEST Journal · doi:10.1378/chest.130.4.982 · Cited by 81
Santis, M. D., Bosello, S. L., Torre, G. L., Capuano, A., Tolusso, B., Pagliari, G., Pistelli, R., Danza, F. M., Zoli, A., & Ferraccioli, G. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-96 · Cited by 75
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis
Beirne, P., Pantelidis, P., Charles, P. J., Wells, A. U., Abraham, D., Denton, C. P., Welsh, K. I., Shah, P. L., du Bois, R. M., & Kelleher, P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00028209 · Cited by 65
Self-citationHosmer, D. W., & Royston, P. J. (2002) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x0200200401 · Cited by 64
STAT3 in tissue fibrosis: Is there a role in the lung?
Knight, D. A., Mutsaers, S. E., & Prêle, C. M. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.10.005 · Cited by 57
Interleukin 6 in Systemic Sclerosis and Potential Implications for Targeted Therapy
Muangchan, C., & Pope, J. E. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111423 · Cited by 51
Increased epithelial permeability in pulmonary fibrosis in relation to disease progression
Goh, N. S. L., Desai, S. R., Anagnostopoulos, C., Hansell, D. M., Hoyles, R. K., Sato, H., Denton, C. P., Black, C. M., du Bois, R. M., & Wells, A. U. (2010) · European Respiratory Journal · doi:10.1183/09031936.00010910 · Cited by 48
Self-citationKondo, K., Okada, T., Matsui, T., Kato, S., Date, K., Yoshihara, M., Nagata, Y., Takagi, H., Yoneda, M., & Sugie, I. (2001) · Cytokine · doi:10.1006/cyto.2000.0822 · Cited by 44
Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis
Lota, H., & Renzoni, E. A. (2012) · International Journal of Rheumatology · doi:10.1155/2012/121439 · Cited by 32
Self-citationAttenuated Lung Fibrosis in Interleukin 6 Knock-out Mice after C-ion Irradiation to Lung
Saito‐Fujita, T., Iwakawa, M., Nakamura, E., Nakawatari, M., Fujita, H., Moritake, T., & Imai, T. (2011) · Journal of Radiation Research · doi:10.1269/jrr.10094 · Cited by 19
Cited by
Denton, C. P., & Khanna, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30933-9 · Cited by 2,212
Self-citationKhanna, D., Denton, C. P., Jahreis, A., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00232-4 · Cited by 683
Self-citationTranslating IL-6 biology into effective treatments
Choy, E. H., De Benedetti, F., Takeuchi, T., Hashizume, M., John, M. R., & Kishimoto, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0419-z · Cited by 668
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Khanna, D., Lin, C. J. F., Furst, D. E., Goldin, J., Kim, G., Kuwana, M., Allanore, Y., Matucci-Cerinic, M., Distler, O., Shima, Y., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30318-0 · Cited by 662
Self-citationVolkmann, E. R., Andréasson, K., & Smith, V. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01692-0 · Cited by 616
Metadata
- Authors
- De Lauretis, A., Sestini, P., Pantelidis, P., Hoyles, R., Hansell, D. M., Goh, N. S. L., Zappala, C. J., Visca, D., Maher, T. M., Denton, C. P., Ong, V. H., Abraham, D. J., Kelleher, P., Hector, L., Wells, A. U., & Renzoni, E. A.
- Venue
- The Journal of Rheumatology
- Publisher
- The Journal of Rheumatology
- Published
- 2013-02-01
- Volume
- 40
- Issue
- 4
- Pages
- 435-446
- ISSN
- 0315-162X (ISSN-L)
- 1499-2752
- OpenAlex
- W2130839876
- Cited by
- 263
- References
- 42
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.